Clinical Trial Update: The Effect of a Probiotic Preparation (VSL#3) Plus Infliximab in Children With Crohn's Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating VSL#3 probiotic plus infliximab in children with Crohn's disease; the current study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Infliximab (infliximab)
• VSL#3

Snippet

Sponsor: Samsung Medical Center | Conditions: Crohn's Disease | Phase 3 | Status: UNKNOWN